Showing results 1 to 2 of 2
| Issue Year | Title | Author(s) | Type | Views | Downloads |
|---|---|---|---|---|---|
| 2023 | Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study | Psyrri, A.; Fayette, J. Vynnychenko; Harrington, K.; Gillison, M.; Ahn, M.-J.; Takahashi, S.; Weiss, J.; Machiels, J.-P.; Baxi, S.; Vasilyev, A.; Karpenko, A.; Dvorkin, M.; Hsieh, C.-Y.; Thungappa, S.C.; Segura, P.P.; Vynnychenko, Ihor Oleksandrovych; Haddad, R.; Kasper, S.; Mauz, P.-S.; Baker, V.; He, P.; Evans, B.; Wildsmith, S.; Olsson, R.F.; Yovine, A.; Kurland, J.F.; Morsli, N.; Seiwert, T.Y. | Article | 10 | 13 |
| 2011 | What is Asperger syndrome? | Symonenko, Nataliia Oleksandrivna; Karpenko, A. | Conference Papers | 6230574 | 15789049 |